GSK’s 5-in-1 meningococcal vaccine Penmenvy receives positive recommendation from US Advisory Committee on Immunization Practices: London, UK Saturday, April 19, 2025, 13:00 Hrs ...

Moderna faces challenges with respiratory vaccine sales and strong competition. Click here to read an analysis of MRNA stock ...

GSK has shifted towards a global marketing ... While the new CEO has made some high-profile changes to the company’s management team, there have been some changes to the way the company ...

In the midst of that, Hanon left GSK in April after 20 years at the company, including seven as ... Meanwhile it is also bringing some other high-profile new vaccines through late-stage ...

Their appointment was initiated by the outgoing board of directors. The four new members will bring many years of experience ...

A new type of antibiotic for treatment of urinary tract infections in women could also work against gonorrhea infections, a ...

GSK PLC closed 25.31% below its 52-week high of £18.24, which the company reached on May 16th.

Blenrep’s potential global reentry also gave GSK confidence to boost its 2031 sales target to more than 40 billion pounds despite uncertainties around the company’s flagship vaccines business.

Eli Lilly's experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood sugar in a trial of ...

GSK’s blood cancer drug Blenrep won regulatory approval in the U.K., marking the medicine’s return to the market after it was ...